Overview

A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

Status:
Completed
Trial end date:
2018-07-08
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety and tolerability of single and multiple doses of TBA-7371 in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Global Alliance for TB Drug Development
Treatments:
Bupropion
Midazolam